Morphine-Sparing Efficacy Of Parecoxib In Pain Treatment After Radical Prostatectomy
Status:
Terminated
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to demonstrate the opioid-sparing efficacy of
parecoxib 40 mg intravenously given as a loading dose followed by 20 mg intravenously in the
24 hours after the end of surgery.